CEO and President L Daniel Browne sold $649K of Revance Therapeutics, Inc.

Sold$649,250

$20.29Price

32,000Shares

−16%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Mon, May 22. Filed Wed, May 24, 5:13 PM ET, after the close. Not investment advice.